NCT01510093View on ClinicalTrials.gov

Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II)

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2013

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Insulin Aspart 100 IE/ml

1.5 IE/hour/subject/visit. Each vist takes 10 hours

Trial Locations (1)

8000

Department of Endocrinology and Internal Diseases, Aarhus C

All Listed Sponsors
lead

Aarhus University Hospital

OTHER

NCT01510093 - Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II) | Biotech Hunter | Biotech Hunter